NVCR$ Anybody done any research or follow Novacure (NASDAQ: NVCR). I stumbled across it today and am starting some DD. Looks like it could be a mover in early December.
The company is expected to release trial data Dec 7th and Dec 12th.
They already have two approved products and revenue is growing.
Chart looks OK and definitely room to run with good data. Institutional ownership is decent.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.